Advanced search
Publication Cover
Adipocyte Volume 11, 2022 - Issue 1
Submit an article Journal homepage
1,217
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

SPRY4 promotes adipogenic differentiation of human mesenchymal stem cells through the MEK–ERK1/2 signaling pathway

Na Lia Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences; Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy (BZ0381), P.R. China;b College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, P.R. ChinaView further author information
,
Yunfei Chena Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences; Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy (BZ0381), P.R. ChinaView further author information
,
Haiyan Wanga Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences; Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy (BZ0381), P.R. ChinaView further author information
,
Jing Lia Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences; Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy (BZ0381), P.R. ChinaCorrespondence[email protected]
View further author information
&
Robert Chunhua Zhaoa Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences; Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy (BZ0381), P.R. China;c Department of Cell Biology, School of Life Sciences, Shanghai University, Shanghai, P.R. ChinaCorrespondence[email protected]
View further author information
Pages 588-600 | Received 15 Jul 2022, Accepted 06 Sep 2022, Published online: 15 Sep 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.